Sign in
4/A

Changes in Ownership

MANNKIND CORP Filed Acc 0001209191-22-047421

EVP Endocrine Business Unit acquired 1,804 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Galindo Alejandro · EVP Endocrine Business Unit

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-31 Grant or award : show line 1 in the form +1,804 $3.17 $5,719 539,790 D
Loading xslF345X03/doc4a.xml…